Medicament for external use for treating onychomycosis

A technology for external use of drugs and onychomycosis, applied in the directions of drug combinations, medical preparations containing active ingredients, pharmaceutical formulas, etc., can solve the problems of long treatment cycle, large skin irritation, difficult lesions, etc. The effect of strong bacterial ability and strong penetration

Inactive Publication Date: 2009-10-28
徐光丽
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Because onychomycosis is more obstinate, the shortcoming that the commonly used medicine in the prior art exists mainly contains: the treatment cycle is long, and the administration period needs half a year even a year; The skin is very irritating, and the pain and burning sensation are strong; the treatment effect is not satisfactory, the lesions are difficult to remove the roots, and the chance of recurrence is high

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicament for external use for treating onychomycosis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] First dry the raw material components, and then batch according to weight ratio:

[0018] 3 parts of strychnium, 1 part of alum, 2 parts of borneol, 2 parts of Ganoderma lucidum powder, 2 parts of griseofulvin tablet

[0019] 1 part sulfur 1 part Thoreau

[0020] Equipped with:

[0021] Mix the above components evenly, then grind into powder, sieve, and adjust the medicine paste with moistening agent lactic acid.

[0022] Medication method: apply the obtained pasty drug on the nail part, wrap the coated drug with adhesive tape, and seal the affected part locally. Sealing and wrapping can increase the local temperature, accelerate the penetration of the drug and kill the fungus on the nail part. After 6 to 7 days, remove the adhesive tape. If the sick nail is detached, the sick nail can be removed to expose a clean nail bed. The exposed nail bed is easier for the drug to penetrate, and the second dressing is applied on the nail bed. The dressing method is the same as ...

Embodiment 2 to Embodiment 4

[0025] The proportioning of each component by weight is listed in Table 1, and the description of the preparation process steps and administration methods of each embodiment of the medicine is the same as that of Example 1.

[0026] Table 1

[0027]

[0028] clinical effect

[0029] 1. Patient profile:

[0030] The present invention is applied to the clinical treatment of 50 cases of onychomycosis (toe) outpatients, including 15 cases of onychomycosis patients and 35 cases of toenail onychomycosis patients, including 35 cases of men and 15 cases of women, the youngest is 21 years old and the largest is 70 years old. 32 cases within 10 years, 18 cases over 10 years.

[0031] The above-mentioned 50 cases were divided into five groups, 10 patients in each group, 7 male patients and 3 female patients in each group, the ages were randomly distributed, and the duration of the disease was randomly distributed.

[0032] 2. The five groups of patients were administered with the p...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicament for external use for treating onychomycosis. Raw material components are dried, the material mixing is performed according to the mixture ratio, the raw material components are evenly mixed and ground, and the powder is sieved and blended into paste by a moistening blender to obtain a finished product. The raw material components comprise the following materials by weight portion: 3 to 5 portions of nux vomica, 1 to 3 portions of alum, 2 to 3 portions of borneol, 2 to 3 portions of glossy ganoderma powder, 2 to 3 portions of griseofulvin tablets, 1 to 3 portions of sulfur, and 1 to 3 portions of semen aesculi. The moistening blender is lactic acid. The medicament has the advantages of short treatment time, no pain during the treatment, convenient treatment, high therapeutic effect, few pharmaceutical components and the like. The medicament can treat and eradicate refractory thymion caused by viruses such as verrucae, voix pedis and the like.

Description

1. Technical field [0001] The invention relates to a medicine for treating gray finger (toe) nail, in particular to an externally used medicine for treating gray finger (toe) nail. 2. Background technology [0002] Onychomycosis (toe) nail, also known as onychomycosis medically, is a disease caused by fungal invasion and infection of finger (toe) nail. The clinical manifestations are deformed, thickened, uneven, rough, dull or discolored nails, and incomplete nails. Onychomycosis has a high incidence rate and strong infectivity. Onychomycosis not only affects the appearance of hands and feet, but also can cause tinea manuum, tinea pedis, tinea corporis and other fungal infectious diseases. [0003] In the prior art, medicines for treating onychomycosis include oral medicines, injection medicines and external medicines, wherein oral medicines and injection medicines have a certain degree of damage to the patient's liver and kidneys, and commonly used external medicines inclu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/56A61P17/00A61P31/10A61K31/045A61K31/343A61K33/04A61K33/06
Inventor 徐光丽
Owner 徐光丽
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products